Overall rank by patents
#22,262
Across all tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 11 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B04B (CENTRIFUGES).
The verdict
BMA holds 12 US patents across 11 technology areas, rank #22,262 of 50,000 tracked assignees.
BMA Braunschweigische Maschinenbauanstalt Ag has been granted 12 US utility patents between 2015 and 2025, placing BMA Braunschweigische Maschinenbauanstalt Ag at rank #22,262 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.3 claims per patent with primary concentration in B04B (CENTRIFUGES). As a Foreign Corporation, BMA Braunschweigische Maschinenbauanstalt Ag is one of the more focused assignees in the PatentsView dataset. By volume, BMA sits between BION Inc. (12 patents, rank #22,258) and Bontac Bio-engineering(shenzhen) Co., Ltd. (12 patents, rank #22,266) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 5 in the 2015–2019 window, a +40% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. BMA Braunschweigische Maschinenbauanstalt Ag's 18.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark BMA Braunschweigische Maschinenbauanstalt Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BION Inc.
12 patents
BIOTECHNOLOGY INSTITUTE, I MAS D, S.L.
12 patents
BIOTHERANOSTICS, INC.
12 patents
BJ SERVICES, LLC
12 patents
BODYFRIEND CO., LTD.
12 patents
BOLD TRANSMISSION, LLC
12 patents
BOLY MEDIA COMMUNICATIONS (SHENZHEN) CO., LTD.
12 patents
BONTAC BIO-ENGINEERING(SHENZHEN) CO., LTD.
12 patents
BMA BRAUNSCHWEIGISCHE MASCHINENBAUANSTALT AG
12 patents
What this shows BMA holds 12 patents at rank #22,262, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,262 in granted patent volume.
Other assignees with the most granted patents in BMA's primary technology class.
BMA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 16.7% |
| 2016 | 1 | 8.3% |
| 2017 | 1 | 8.3% |
| 2019 | 1 | 8.3% |
| 2020 | 2 | 16.7% |
| 2022 | 1 | 8.3% |
| 2023 | 1 | 8.3% |
| 2024 | 2 | 16.7% |
| 2025 | 1 | 8.3% |
Top 11 of 11 technology areas
Overall rank by patents
#22,262
Across all tracked assignees
40.4 out of 100
How to use this portfolio
BMA's 12 grants land it in the top 36% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.